This is a $1,998,978.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian federal agency, to Light Research Inc., a for-profit small business. The contract is for Phase 2 of a Small Business Innovation Research (SBIR) program, under Topic 431 "LIGHT RESEARCH". The contract has a Total Small Business set-aside and an ultimate completion date of September 15, 2026. Light Research Inc. is a small business that provides research, development, and...
The U.S. National Cancer Institute awarded a $1,499,984.00 Small Business Innovation Research (SBIR) Phase II contract to Intelligent Optical Systems, Inc., a manufacturer of optical sensing and instrumentation technologies based in Torrance, California. The contract is for the development of a biopsy optical sensor for in situ tissue analysis under Topic 331. This is a Definitive Contract with a Cost Plus Fixed Fee pricing type, and the work is expected to be completed by September 18, 2021....
This federal contract award, valued at $224,984.00, was made by the National Cancer Institute (NCI), a civilian agency, to Intelligent Optical Systems, Inc., a small business manufacturer of optical sensing and instrumentation technologies. The contract was awarded under the Small Business Innovation Research (SBIR) program, Phase I, for the development of a biopsy optical sensor for in-situ tissue analysis. This specialized sensor technology is intended to support the NCI's mission in...
This $400,000 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Amplifidx Inc., a woman-owned small business. The contract supports the development of cancer prevention and diagnosis technologies for low-resource settings over a two-year period. This award aligns with NCI's mission to support innovative medical device research and development by small businesses. As a SBIR...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), an institute of the National Institutes of Health (NIH), to Lucidact Inc., a minority-owned and disadvantaged small business located in Los Angeles, CA. The $454,524 fixed-price contract is for the development of a digital tool to integrate cancer prevention within primary care, as part of the broader SBIR program objectives to stimulate technological innovation and strengthen the...
This $399,987 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH), to Care Progress LLC, a small business limited liability company. The contract supports the development of cancer clinical trials recruitment and retention tools for participant engagement, as described in the original SBIR solicitation. The solicitation sought proposals for SBIR Phase I and Phase II contracts to conduct...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Phenomapper, LLC, a minority-owned, self-certified small disadvantaged business located in San Jose, California. The $398,952.00 firm-fixed-price contract was awarded on September 16, 2020, with a completion date of September 15, 2021. The contract is for the development of artificial intelligence-aided imaging technology...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Woodtoga Holdings Company, a for-profit manufacturer, for the development of "Applicator-Compatible Electronic Brachytherapy Sources for Cancer Radiotherapy." The $399,779.00 firm fixed price contract runs through December 31, 2022 and is set aside for small businesses. This contract supports the SBIR program...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Radiologics, Inc., a for-profit organization. The contract, valued at $225,000.00, is for the development of FDA-compliant imaging informatics for cancer research under SBIR Topic 365. As a SBIR Phase I award, this contract is set aside for small businesses. The contract has a firm fixed price pricing type and was awarded on September 18, 2017, with...
This is a $382,034 Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Phoenix Biosystem, Inc., a self-certified small disadvantaged business. The contract is for the development of HPV point-of-care molecular diagnostics for low- and middle-income countries. The original pre-solicitation announced that NIH and CDC were seeking SBIR proposals to advance their infectious...